Register for email alerts and news feeds:
This journal | BMJ Group
rss
Gut 2006;55:1217
Copyright © 2006 BMJ Publishing Group Ltd & British Society of Gastroenterology.

Digest

Robin Spiller, Editor, Alastair Watson, Deputy Editor

The first 150 words of the full text of this article appear below.

ABLATION OF BARRETT’S OESOPHAGUS: THE GOOD AND BAD NEWS

With the rising incidence of adenocarcinoma of the oesophagus, a method of eliminating Barrett’s oesophagus would be a step forward. The authors randomised 35 patients with Barrett’s oesophagus to ablative treatment with either multipolar electrocoagulation or argon beam coagulation. The good news is that both treatments eliminated Barrett’s oesophagus at 2 years in approximately 70% of patients, with neither treatment showing any statistical advantage over the other. Adverse events and outcomes were rare. Unfortunately it was not possible to identify risk factors for treatment failure. The bad news is that ablative treatment does not eliminate the need for surveillance as ablation is incomplete in 30% of patients. Repeated biopsies are required of the previous Barrett’s area to identify these treatment failures. Furthermore, it is still unknown whether such ablative treatment reduces the risk of subsequent adenocarcinoma. The authors conclude ablative treatment is not yet ready for clinical practice except as . . . [Full text of this article]


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?

Relevant Articles

A randomised controlled trial of ablation of Barrett’s oesophagus with multipolar electrocoagulation versus argon plasma coagulation in combination with acid suppression: long term results
P Sharma, S Wani, A P Weston, A Bansal, M Hall, S Mathur, A Prasad, and R E Sampliner
Gut 2006 55: 1233-1239. [Abstract] [Full Text] [PDF]

Cost effectiveness of interferon {alpha} or peginterferon {alpha} with ribavirin for histologically mild chronic hepatitis C
R Grieve, J Roberts, M Wright, M Sweeting, D DeAngelis, W Rosenberg, M Bassendine, J Main, and H Thomas
Gut 2006 55: 1332-1338. [Abstract] [Full Text] [PDF]

The gut–joint axis: cross reactive food antibodies in rheumatoid arthritis
M Hvatum, L Kanerud, R Hällgren, and P Brandtzaeg
Gut 2006 55: 1240-1247. [Abstract] [Full Text] [PDF]

Hepatic stellate cells express synemin, a protein bridging intermediate filaments to focal adhesions
N Uyama, L Zhao, E Van Rossen, Y Hirako, H Reynaert, D H Adams, Z Xue, Z Li, R Robson, M Pekny, and A Geerts
Gut 2006 55: 1276-1289. [Abstract] [Full Text] [PDF]

Survival and cause specific mortality in patients with inflammatory bowel disease: a long term outcome study in Olmsted County, Minnesota, 1940–2004
T Jess, E V Loftus, Jr, W S Harmsen, A R Zinsmeister, W J Tremaine, L J Melton, III, P Munkholm, and W J Sandborn
Gut 2006 55: 1248-1254. [Abstract] [Full Text] [PDF]

Insulin-like growth factor I improves intestinal barrier function in cirrhotic rats
V Lorenzo-Zúñiga, C M Rodríguez-Ortigosa, R Bartolí, M-L Martínez-Chantar, L Martínez-Peralta, A Pardo, I Ojanguren, J Quiroga, R Planas, and J Prieto
Gut 2006 55: 1306-1312. [Abstract] [Full Text] [PDF]

This Article

Services
Citing Articles
Google Scholar
PubMed
Topic Collections
Bookmark with

Register for free content

The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.

Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.

Cardiology Jobs

Gastroenterology Jobs